Some U.S. Employers Plan to End Coverage of Weight-Loss Drugs as Costs Continue to Rise
Large employers in the United States are increasingly reconsidering coverage for GLP-1 weight-loss medications such as Wegovy, Zepbound, and Foundayo as growing demand continues to drive healthcare costs higher. According to recent surveys, around...